Among the biological parameters proposed as possible prognostic factors in ovarian cancer, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor- type 2 (HER-2/neu) have been tested as potential biomarkers that guide individualized treatment of the cancer5,6,9. The gene discussed is ERBB2; the disease is ovarian carcinoma.